Analysis of sampling volume and tissue heterogeneity on the in vivo detection of fluorescence.

The effect of sampling region size and tissue heterogeneity is examined using fluorescence histogram assessment in a rat prostate tumor model with benzoporphyrin derivative fluorophore. Spatial heterogeneity in the fluorescence signal occurs on both macroscopic and microscopic scales. The periphery of the tumor is more fluorescent than the center. Fluorescence is also highest nearest the blood vessels immediately after injection, but over time this fluorescence becomes uniform through the tumor tissue. Using microscopy analysis, the fluorescence intensity histogram distributions follow a normal distribution, yet as the sampling area is increased from the micron scale to the millimeter scale, the variance of the distribution decreases. The mean fluorescence intensity is accurately measured with a millimeter size scale, but this cannot provide accurate measurements of the microscopic variance of drug in tissue. Fiber probe measurements taken in vivo are used to confirm that the variance observed is smaller than would be expected with microscopic sampling, but that the average fluorescence can be measured with fibers. Sampling tissue with fibers smaller than the intercapillary spacing could provide a way to estimate the spatial variance more accurately. In summary, sampling fiber size affects the fluorescence intensities detected and use of multiple region microscopic sampling could provide better information about the distribution of values that occur.

[1]  A E Profio,et al.  Fluorescence of HpD for tumor detection and dosimetry in photoradiation therapy. , 1984, Progress in clinical and biological research.

[2]  Gerald J. Smith,et al.  THE EFFECTS OF AGGREGATION ON THE FLUORESCENCE and THE TRIPLET STATE YIELD OF HEMATOPORPHYRIN , 1985 .

[3]  H. Barr,et al.  Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. , 1987, British Journal of Cancer.

[4]  D. Dolphin,et al.  Preliminary studies on a more effective phototoxic agent than hematoporphyrin. , 1987, Journal of the National Cancer Institute.

[5]  D. Dolphin,et al.  Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. , 1990, Journal of photochemistry and photobiology. B, Biology.

[6]  M S Patterson,et al.  In vivo TESTS OF THE CONCEPT OF PHOTODYNAMIC THRESHOLD DOSE IN NORMAL RAT LIVER PHOTOSENSITIZED BY ALUMINUM CHLOROSULPHONATED PHTHALOCYANINE , 1990, Photochemistry and photobiology.

[7]  Q. Peng,et al.  A transient reduction of the fluorescence of aluminium phthalocyanine tetrasulphonate in tumours during photodynamic therapy. , 1990, Journal of photochemistry and photobiology. B, Biology.

[8]  Michael S. Patterson,et al.  Dependence of photodynamic threshold dose on treatment parameters in normal rat liver in vivo , 1991, Photonics West - Lasers and Applications in Science and Engineering.

[9]  J Moan,et al.  Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. , 1990, Cancer letters.

[10]  Stefan Andersson-Engels,et al.  In vivo fluorescence in clinical oncology: fundamental and practical issues , 1992 .

[11]  B. Henderson,et al.  Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy. , 1992, The Journal of surgical research.

[12]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  B F Overholt,et al.  Quantification of phthalocyanine concentration in rat tissue using laser–induced fluorescence spectroscopy , 1993, Lasers in surgery and medicine.

[14]  C. Grau,et al.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. , 1994, International journal of radiation oncology, biology, physics.

[15]  T. Hasan,et al.  PHOTOPHYSICAL AND PHOTOSENSITIZING PROPERTIES OF BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD‐MA) * , 1994, Photochemistry and photobiology.

[16]  T. Hasan,et al.  The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). , 1995, Journal of photochemistry and photobiology. B, Biology.

[17]  S L Jacques,et al.  Fluorescence spectroscopy of tissue: recovery of intrinsic fluorescence from measured fluorescence. , 1996, Applied optics.

[18]  B. Pogue,et al.  Fluorophore quantitation in tissue-simulating media with confocal detection , 1996 .

[19]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[20]  B C Wilson,et al.  A solubilization technique for photosensitizer quantification in ex vivo tissue samples. , 1997, Journal of photochemistry and photobiology. B, Biology.

[21]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[22]  K Svanberg,et al.  In vivo fluorescence imaging for tissue diagnostics. , 1997, Physics in medicine and biology.

[23]  B W Pogue,et al.  Fiber-optic bundle design for quantitative fluorescence measurement from tissue. , 1998, Applied optics.

[24]  R. Redmond,et al.  Environmental Effects on Cellular Photosensitization: Correlation of Phototoxicity Mechanism with Transient Absorption Spectroscopy Measurements , 1998, Photochemistry and photobiology.

[25]  T. Hasan,et al.  In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. , 1999, Cancer research.

[26]  R. Redmond,et al.  Can Cellular Phototoxicity be Accurately Predicted on the Basis of Sensitizer Photophysics? , 1999, Photochemistry and photobiology.

[27]  H W Wang,et al.  Quantitative Analysis of Pc 4 Localization in Mouse Lymphoma (LY-R) Cells via Double-label Confocal Fluorescence Microscopy , 2000, Photochemistry and photobiology.

[28]  Brian W. Pogue,et al.  Estimation of Oxygen Distribution in RIF-1 Tumors by Diffusion Model-Based Interpretation of Pimonidazole Hypoxia and Eppendorf Measurements , 2001, Radiation research.

[29]  Gregory C. Burke,et al.  Comparison of Photosensitizer (AlPcS2) Quantification Techniques: In Situ Fluorescence Microsampling Versus Tissue Chemical Extraction¶ , 2001, Photochemistry and photobiology.

[30]  B. Pogue,et al.  Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B. , 2003, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[31]  Brian W. Pogue,et al.  Blood Flow Dynamics after Photodynamic Therapy with Verteporfin in the RIF-1 Tumor , 2003, Radiation research.

[32]  P Jack Hoopes,et al.  Assessment of Photosensitizer Dosimetry and Tissue Damage Assay for Photodynamic Therapy in Advanced‐stage Tumors ¶ , 2004, Photochemistry and photobiology.

[33]  B. Pogue,et al.  Analysis of Effective Molecular Diffusion Rates for Verteporfin in Subcutaneous Versus Orthotopic Dunning Prostate Tumors¶ , 2004, Photochemistry and photobiology.

[34]  Bin Chen,et al.  Fluorescence Imaging in Vivo: Raster Scanned Point-Source Imaging Provides More Accurate Quantification than Broad Beam Geometries , 2004, Technology in cancer research & treatment.

[35]  Brian C. Wilson,et al.  Effect of photosensitizer concentration in tissue on the penetration depth of photoactivating light , 1986, Lasers in Medical Science.

[36]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.